Evidence map›Paper›PMID 39723655›Full record

ArticleGM crops & food2025

Distribution status of genetically modified soybeans from the United States and Canada to Japan in 2021 and 2022.

Keisuke Soga, Yu Hashimoto, Tomohiro Egi, Chie Taguchi, Satoko Yoshiba, Norihito Shibata, Kazunari Kondo, Reona Takabatake

Abstract read
In one paragraph

Article in GM crops & food, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Keisuke SogaDivision of Biochemistry, National Institute of Health Sciences, Kanagawa, Japan.ORCID 0000-0001-7387-468X
Yu HashimotoDivision of Analytical Science, Food Research Institute, National Agriculture and Food Research Organization, Tsukuba, Ibaraki, Japan.
Tomohiro EgiFood Labeling Monitoring Department, Food and Agricultural Materials Inspection Center, Saitama, Japan.
Chie TaguchiDivision of Biochemistry, National Institute of Health Sciences, Kanagawa, Japan.ORCID 0000-0003-3012-8382
Satoko YoshibaDivision of Biochemistry, National Institute of Health Sciences, Kanagawa, Japan.ORCID 0000-0002-9415-3619
Norihito ShibataDivision of Biochemistry, National Institute of Health Sciences, Kanagawa, Japan.ORCID 0000-0001-5792-8510
Kazunari KondoDivision of Biochemistry, National Institute of Health Sciences, Kanagawa, Japan.ORCID 0000-0002-2662-4626
Reona TakabatakeDivision of Analytical Science, Food Research Institute, National Agriculture and Food Research Organization, Tsukuba, Ibaraki, Japan.ORCID 0000-0001-6419-7314

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The number of authorized genetically modified (GM) soybeans has increased worldwide. In Japan, 34 GM soybeans containing single events and their stacked varieties have been approved as food. However, not all approved GM events are commercially cultivated or distributed. In this study, we evaluated domestically distributed samples from the United States (US) and Canada using 17 event-specific detection methods for GM soybeans. Identity-preserved (IP) soybean samples imported from the US and Canada, and non-IP samples from the US in 2021 and 2022 were analyzed. Four GM soybean events consisting of MON89788, A5547-127, MON87708, and DAS-44406 were detected in all lots in the non-IP samples. Furthermore, a single-kernel-based analysis was conducted to determine whether the detected GM soybean events are stacked. The results suggest that DAS-44406 is rapidly increasing, particularly as a single event among GM soybeans.

Indexed as

Glycine maxPlants, Genetically ModifiedCanadaFood, Genetically ModifiedJapanUnited StatesDistributioneventgenetically modified (GM)soybeanstacked variety

Identifiers

PMID39723655
PMCPMC11702959

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.